Angiotensin II modulates interleukin-1β-induced inflammatory gene expression in vascular smooth muscle cells via interfering with ERK-NF-κB crosstalk

Biochemical and Biophysical Research Communications

Volumn 410, Issue 3, 2011, Pages 543-548

  Xu, Shanqin ^a   Zhi, Hui ^b   Hou, Xiuyun ^a   Jiang, Bingbing ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adhesion molecules; Angiotensin; Inflammation; Nitric oxide; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; S6 KINASE; VASCULAR CELL ADHESION MOLECULE 1;

ADVENTITIA; ANIMAL CELL; ANIMAL TISSUE; AORTA ARCH; ARTICLE; DOWN REGULATION; ENDOTHELIUM CELL; GENE EXPRESSION; IN VIVO STUDY; INFLAMMATION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE; WILD TYPE;

ANGIOTENSIN II; ANIMALS; AORTA; APOLIPOPROTEINS E; CARDIOVASCULAR DISEASES; DOWN-REGULATION; DUAL SPECIFICITY PHOSPHATASE 1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; INFLAMMATION; INTERLEUKIN-1BETA; MICE; MICE, MUTANT STRAINS; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; RATS; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; VASCULAR CELL ADHESION MOLECULE-1;

MUS; RATTUS;

EID: 79960060935     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.021     Document Type: Article

References (29)

1. Ohishi M., Ueda M., Rakugi H., Naruko T., Kojima A., Okamura A., Higaki J., Ogihara T. Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humans. J. Hypertens. 1997, 15:1295-1302.
2. Weiss D., Kools J.J., Taylor W.R. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation 2001, 103:448-454.
3. Candido R., Allen T.J., Lassila M., Cao Z., Thallas V., Cooper M.E., Jandeleit-Dahm K.A. Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis. Circulation 2004, 109:1536-1542.
4. Graninger M., Reiter R., Drucker C., Minar E., Jilma B. Angiotensin receptor blockade decreases markers of vascular inflammation. J. Cardiovasc. Pharmacol. 2004, 44:335-339.
5. Marchesi C., Paradis P., Schiffrin E.L. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol. Sci. 2008, 29:367-374.
6. Le Bail O., Schmidt-Ullrich R., Israel A. Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family. EMBO J. 1993, 12:5043-5049.
7. Thompson J.E., Phillips R.J., Erdjument-Bromage H., Tempst P., Ghosh S. I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell 1995, 80:573-582.
8. Wu C., Ghosh S. Differential phosphorylation of the signal-responsive domain of I kappa B alpha and I kappa B beta by I kappa B kinases. J. Biol. Chem. 2003, 278:31980-31987.
9. Hoffmann A., Levchenko A., Scott M.L., Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 2002, 298:1241-1245.
10. Hoffmann A., Leung T.H., Baltimore D. Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. EMBO J. 2003, 22:5530-5539.
11. Jiang B., Xu S., Hou X., Pimentel D.R., Brecher P., Cohen R.A. Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1beta-induced gene expression. J. Biol. Chem. 2004, 279:1323-1329.
12. Jiang B., Xu S., Hou X., Pimentel D.R., Cohen R.A. Angiotensin II differentially regulates interleukin-1-beta-inducible NO synthase (iNOS) and vascular cell adhesion molecule-1 (VCAM-1) expression: role of p38 MAPK. J. Biol. Chem. 2004, 279:20363-20368.
13. Jiang B., Brecher P., Cohen R.A. Persistent activation of nuclear factor-kappaB by interleukin-1beta and subsequent inducible NO synthase expression requires extracellular signal-regulated kinase. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1915-1920.
14. Gu M., Brecher P. Nitric oxide-induced increase in p21(Sdi1/Cip1/Waf1) expression during the cell cycle in aortic adventitial fibroblasts. Arterioscler. Thromb. Vasc. Biol. 2000, 20:27-34.
15. Xu S., Bayat H., Hou X., Jiang B. Ribosomal S6 kinase-1 modulates interleukin-1beta-induced persistent activation of NF-kappaB through phosphorylation of IkappaBbeta. Am. J. Physiol. Cell Physiol. 2006, 291:C1336-C1345.
16. Matsui R., Xu S., Maitland K.A., Mastroianni R., Leopold J.A., Handy D.E., Loscalzo J., Cohen R.A. Glucose-6-phosphate dehydrogenase deficiency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E(-/-) mice. Arterioscler. Thromb. Vasc. Biol. 2006, 26:910-916.
17. Xu S., Jiang B., Maitland K.A., Bayat H., Gu J., Nadler J.L., Corda S., Lavielle G., Verbeuren T.J., Zuccollo A., Cohen R.A. The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice. Diabetes 2006, 55:110-119.
18. Duff J.L., Monia B.P., Berk B.C. Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Effect of actinomycin D and antisense oligonucleotides. J. Biol. Chem. 1995, 270:7161-7166.
19. Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., Davis V., Gutierrez-Ramos J.C., Connelly P.W., Milstone D.S. A major role for VCAM-1, but not ICAM-1. In early atherosclerosis. J. Clin. Invest. 2001, 107:1255-1262.
20. Jongstra-Bilen J., Haidari M., Zhu S.N., Chen M., Guha D., Cybulsky M.I. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J. Exp. Med. 2006, 203:2073-2083.
21. Surapisitchat J., Hoefen R.J., Pi X., Yoshizumi M., Yan C., Berk B.C. Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: inhibitory crosstalk among MAPK family members. Proc. Natl. Acad. Sci. USA 2001, 98:6476-6481.
22. Yan Z., Hansson G.K. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ. Res. 1998, 82:21-29.
23. Koglin J., Glysing-Jensen T., Mudgett J.S., Russell M.E. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circulation 1998, 97:2059-2065.
24. Cooney R., Hynes S.O., Sharif F., Howard L., O'Brien T. Effect of gene delivery of NOS isoforms on intimal hyperplasia and endothelial regeneration after balloon injury. Gene Ther. 2007, 14:396-404.
25. Detmers P.A., Hernandez M., Mudgett J., Hassing H., Burton C., Mundt S., Chun S., Fletcher D., Card D.J., Lisnock J., Weikel R., Bergstrom J.D., Shevell D.E., Hermanowski-Vosatka A., Sparrow C.P., Chao Y.S., Rader D.J., Wright S.D., Pure E. Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J. Immunol. 2000, 165:3430-3435.
26. Kuhlencordt P.J., Chen J., Han F., Astern J., Huang P.L. Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation 2001, 103:3099-3104.
27. Miyoshi T., Li Y., Shih D.M., Wang X., Laubach V.E., Matsumoto A.H., Helm G.A., Lusis A.J., Shi W. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice. Life Sci. 2006, 79:525-531.
28. Graham A., Hogg N., Kalyanaraman B., O'Leary V., Darley-Usmar V., Moncada S. Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett. 1993, 330:181-185.
29. Ginnan R., Guikema B.J., Halligan K.E., Singer H.A., Jourd'heuil D. Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases. Free Radic. Biol. Med. 2008, 44:1232-1245.